ADDITIONAL INFO

Semaglutide — Research Peptide

Semaglutide is a synthetic, long-acting peptide analog of glucagon-like peptide-1 (GLP-1) designed to activate GLP-1 receptors in research models. It is structurally modified to resist enzymatic breakdown and extend activity, making it useful for laboratory studies involving glucose regulation, appetite signaling, gastric emptying, and metabolic pathway analysis.

Product Details

• Compound Name: Semaglutide

• Compound Type: Synthetic GLP-1 receptor agonist peptide

• Sequence Class: Modified GLP-1 analog with fatty-acid side chain for extended stability

• Net Contents: 5 mg-20mg lyophilized peptide powder per vial (size varies by batch) (3mL)

• Form: Lyophilized (freeze-dried) powder

• Primary Target: GLP-1 receptor

• Mechanism Studied: GLP-1 receptor activation and downstream metabolic signaling

• Purity: ≥99% (HPLC tested; Certificate of Analysis available)

• Manufactured in: GMP-compliant facility

• Intended Use: Laboratory research use only — not for human or veterinary use

Research Applications
Semaglutide is used in research settings to study:

• GLP-1 receptor signaling pathways

• Glucose and insulin response mechanisms

• Appetite and satiety signaling

• Gastric emptying and GI motility effects

• Energy balance and metabolic regulation

Storage & Handling

• Store unopened vial frozen at −20 °C

• Keep dry and protected from light

• After reconstitution, refrigerate at 2–8 °C

• Avoid repeated freeze–thaw cycles

• Use sterile technique when handling and reconstituting

Research Use Notice:
Provided strictly for laboratory research purposes only. Not intended for human consumption, medical, diagnostic, or therapeutic applications.